Posttreatment Surveillance Frequency Not Related To Improved Lung Cancer Patient Survival | Latest News RSS feed

Posttreatment Surveillance Frequency Not Related To Improved Lung Cancer Patient Survival - Latest News


Roche reports very strong growth in the first nine months of 2018

While a numerical improvement of 4.5 months for the co-primary endpoint of overall survival (OS) was observed, at this interim analysis statistical significance has not yet been met. Roche ... read more

Stratification of risk groups according to survival after recurrence in endometrial cancer patients

Patients who received fertility-sparing treatment, lacked follow-up information, did not have a disease-free ... The advancements in cancer care and treatment during this long period may have improved ... read more

Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer

A 2006 randomized trial demonstrated a 16-month survival benefit with intraperitoneal and intravenous (IP/IV) chemotherapy administered to patients who had ovarian cancer, compared with IV chemotherap... read more

Looking for another news?


F. Hoffmann-La Roche Ltd - Roche reports very strong growth in the first nine months of 2018

The 30% sales increase of Perjeta was driven by its use for adjuvant (after surgery) treatment of patients with HER2-positive early breast cancer ... overall survival (OS) was observed, at this interi... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us